Nabota, a botulinum toxin type A product, has gained significant popularity in the aesthetic and medical fields due to its effectiveness in treating various conditions. Produced by Daewoong Pharmaceutical, a South Korean company, Nabota has been praised for its high purity, quick onset of action, and long-lasting results.
Nabota Botox, manufactured by Daewoong Pharmaceutical Co., Ltd., is a type of botulinum toxin type A injection that is used to reduce the appearance of wrinkles and fine lines. It works by temporarily paralyzing the muscles responsible for causing wrinkles, leading to smoother and younger-looking skin. The formulation of Nabota Botox is designed to provide long-lasting results, making it a popular choice among individuals seeking non-invasive anti-aging treatments.
Nabota botulinum toxin type A functions by blocking nerve signals to the injected muscles. The process reduces muscle activity and helps alleviate symptoms of various conditions. For medical treatments, such as upper limb spasticity and urinary incontinence, Nabota offers temporary improvement by relaxing the targeted muscles.
For cosmetic treatments, Nabota acts fast to smooth out facial lines and wrinkles. The initial effect is noticeable within days, providing a refreshed appearance. Nabota's shelf life and stable formulation ensure consistent results, making it a reliable option for practitioners.
Wrinkle Reduction: Nabota is widely used to treat dynamic wrinkles, such as frown lines, crow's feet, and forehead lines. Its quick onset of action and long duration make it a preferred choice for many practitioners.
Facial Contouring: Nabota can also be used for non-surgical facial contouring, such as slimming the jawline by reducing the masseter muscle's size.
Hyperhidrosis: Excessive sweating, particularly in the underarms, hands, and feet, can be effectively managed with Nabota injections.
Cervical Dystonia: Nabota has been approved for the treatment of cervical dystonia, a condition characterized by abnormal neck muscle contractions.
Chronic Migraine: Patients suffering from chronic migraines may find relief through Nabota injections, which can help reduce the frequency and severity of migraine attacks.
Spasticity: Nabota is used in the management of spasticity associated with conditions such as cerebral palsy and post-stroke.
Several clinical studies have demonstrated the efficacy of Nabota in both aesthetic and therapeutic applications. In comparative studies, Nabota has shown similar or superior effectiveness compared to other established botulinum toxin products.
For wrinkle reduction, patients typically begin to see results within 2-3 days of injection, with peak effects observed at around 1-2 weeks. The effects can last for up to 4-6 months, depending on the individual and the treated area. This duration is comparable to other botulinum toxin products, making Nabota a competitive option in the market.
In the treatment of medical conditions like cervical dystonia and chronic migraines, Nabota has been found to significantly improve patients' quality of life. Reduced muscle spasticity and fewer migraine days have been reported, along with an overall improvement in functionality and daily living activities.
User feedback for Nabota has been overwhelmingly positive, with many patients and practitioners praising its rapid onset of action and lasting results. Patients appreciate the natural-looking outcomes, which contribute to a refreshed and youthful appearance without the "frozen" look often associated with botulinum toxin treatments.
Practitioners have highlighted the ease of use and the consistent results achieved with Nabota. The product's stability and precise dosing make it a reliable choice for various applications. Additionally, the competitive pricing of Nabota compared to other premium botulinum toxin products has made it an attractive option for both clinics and patients.
To address glabellar lines (forehead wrinkles): Using a 30 gauge needle, inject the dissolved product into the corrugator muscles and the procerus muscle (a total of 5 areas). 0.1ml of the product should be injected in each area, with a total of 20 U being injected.
When injecting into the inner corrugator supercilii muscle and the medial eyebrows, inject at least 1 cm from the edge of the eye. During injection, the needle should be aimed at the upper center, and the injection volume should be accurate. Careful attention should be paid to NOT inject Nabota 100 U into the blood vessel. To prevent Nabota 100 U from being injected into the blood vessel(exudation) below the orbital ridge, place the thumb or index finger below the orbital ridge prior to injection.
The corrugator muscle and the orbicularis oculi muscle move in the middle of the forehead to make glabellar folds on the face. The procerus muscle and the depressor supercilii muscle pull the forehead downward. These muscles create frown lines or wrinkles. Because the muscle position, muscle size, and use of muscle vary from person to person, the effective dose is determined by complete observation of the patient's ability to control the implanted surface muscles.